✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Idorsia Ltd

Common Name
Idorsia
Country
Switzerland
Sector
Healthcare
Industry
Biotechnology
Employees
N/A
Ticker
IDIA
Exchange
SIX SWISS EXCHANGE
Description
Idorsia Ltd. is a biopharmaceutical company that engages in the discovery, development, and commercialization of innovative medicines. Its primary purpose is to transform patient care through novel th...

Idorsia's GHG Emissions Data Preview

In 2024, Idorsia completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, Idorsia has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Limited Data Preview
You are viewing a limited preview of Idorsia’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2022, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=IDIA&reporting_period=2024"

Verified Sources Behind Idorsia’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Idorsia’s data sources below and access millions more through our Disclosure Search.

a. Idorsia's Sustainability Report 2024

Insights into Idorsia's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Idorsia amounted to 762.6 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Idorsia decreased by 22.41%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Idorsia's Scope 1 Emissions Over Time

2022202320240200400600800tCO2e+15%+54%
  • Total Scope 1
  • Year-over-Year Change

What are Idorsia's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Idorsia were 733.4 metric tons of CO₂ equivalent (tCO₂e).a

Has Idorsia reduced its Scope 1 emissions over time?

Since 2022, Idorsia's Scope 1 emissions have increased by 77.49%, reflecting a rising long-term trend in Scope 1 emissions over time.a

Compared to the previous year (2023), Idorsia's Scope 1 emissions increased by 54.4%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Idorsia's Scope 2 emissions?

In 2024, Idorsia reported Scope 2 greenhouse gas (GHG) emissions of 29.2 tCO₂e without specifying the calculation method.a

Has Idorsia reduced its Scope 2 emissions over time?

Since 2022, Idorsia's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 92.7%, reflecting a declining long-term trend in Scope 2 emissions over time.a

Compared to the previous year (2023), Idorsia's Scope 2 emissions (Unspecified Calculation Method) fell by 94.25% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a

What methodology does Idorsia use for Scope 2 reporting?

In 2024, Idorsia reported its Scope 2 emissions using an unspecified methodology.a

Idorsia's Scope 2 Emissions Over Time

2022202320240150300450600tCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Idorsia's Value Chain Emissions

In 2024, Idorsia reported 68,495.3 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Idorsia includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Idorsia's Scope 3 Emissions Over Time

2024020 k40 k60 k80 ktCO2e
  • Total Scope 3
  • Year-over-Year Change

What are Idorsia's Scope 3 emissions?

In 2024, Idorsia reported total Scope 3 emissions of 68,495.3 metric tons of CO₂ equivalent (tCO₂e).a

Insights into Idorsia’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Idorsia reported Scope 1 greenhouse gas (GHG) emissions of 733.4 tCO₂e and total revenues of USD 124 millions. This translates into an emissions intensity of 5.9 tCO₂e per millions USD.a

Idorsia's Scope 1 Emissions Intensity Compared to Peers

0.51050010,000200,000Scope 1 Emissions (tCO2e)5505005,000100,000Revenues (Millions of USD)BInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MPharma MarYear: 2023Scope 1: 1,233 tCO2eRevenue: $M 175Scope 1 Intensity: 7.04 tCO2e/$MBBBlue Jet HealthcareYear: 2025Scope 1: 23,877 tCO2eRevenue: $M 120Scope 1 Intensity: 198.82 tCO2e/$MBB BiotechYear: 2024Scope 1: 12 tCO2eRevenue: $M 91Scope 1 Intensity: 0.13 tCO2e/$MEverest MedicinesYear: 2024Scope 1: 1 tCO2eRevenue: $M 106Scope 1 Intensity: 0.00 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MMedartis HoldingYear: 2024Scope 1: 877 tCO2eRevenue: $M 248Scope 1 Intensity: 3.53 tCO2e/$MSK BiopharmaceuticalsYear: 2024Scope 1: 414 tCO2eRevenue: $M 373Scope 1 Intensity: 1.11 tCO2e/$MPeptiDreamYear: 2023Scope 1: 3,156 tCO2eRevenue: $M 203Scope 1 Intensity: 15.55 tCO2e/$MSK BioscienceYear: 2023Scope 1: 5,863 tCO2eRevenue: $M 289Scope 1 Intensity: 20.28 tCO2e/$MBiotestYear: 2020Scope 1: 18,574 tCO2eRevenue: $M 384Scope 1 Intensity: 48.41 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MSamsung BiologicsYear: 2024Scope 1: 71,972 tCO2eRevenue: $M 3,099Scope 1 Intensity: 23.22 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MAdimmuneYear: 2023Scope 1: 4,556 tCO2eRevenue: $M 58Scope 1 Intensity: 78.30 tCO2e/$MGubraYear: 2024Scope 1: 8 tCO2eRevenue: $M 37Scope 1 Intensity: 0.22 tCO2e/$MCelltrionYear: 2024Scope 1: 27,147 tCO2eRevenue: $M 2,424Scope 1 Intensity: 11.20 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MBeOne MedicinesYear: 2024Scope 1: 3,547 tCO2eRevenue: $M 27,369Scope 1 Intensity: 0.13 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MZealand PharmaYear: 2024Scope 1: 145 tCO2eRevenue: $M 9Scope 1 Intensity: 16.60 tCO2e/$MIdorsiaYear: 2024Scope 1: 733 tCO2eRevenue: $M 124Scope 1 Intensity: 5.90 tCO2e/$M

How does Idorsia's GHG emissions intensity compare to its peers?

In 2024, Idorsia reported a Scope 1 emissions intensity of 5.9 tCO₂e per millions USD. Compared to the peer group median of 6.86, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Idorsia rank on GHG emissions intensity within its industry?

In 2024, Idorsia ranked 12 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Idorsia is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Insights into Idorsia's Total Carbon Footprint

In 2024, Idorsia reported a total carbon footprint of 69,257.9 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 6,947% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Idorsia's total carbon footprint was Scope 3 emissions, accounting for 98.9% of the company's total carbon footprint, followed by Scope 1 emissions at 1.06%.a

Want Full Access to Idorsia's GHG Emissions Dataset?
Start 30-Day Free Trial